What does the pharmacotherapy for Parkinson's disease intended to do?

A. Increase the amount of dopamine and reduce the amount of acetylcholine: This is the correct answer. Parkinson's disease is characterized by a deficiency of dopamine, so medications aim to increase dopamine levels. Additionally, reducing the activity of acetylcholine helps to restore the balance between these neurotransmitters. B. Increase the amount of dopamine and acetylcholine: This is not accurate. Increasing both dopamine and acetylcholine would not address the underlying imbalance seen in Parkinson's disease. C. Reduce the amount of dopamine and increase the amount of acetylcholine: This is incorrect. Parkinson's disease involves a reduction in dopamine levels, so reducing dopamine further would worsen the symptoms. Additionally, increasing acetylcholine is not the therapeutic goal in Parkinson's disease. D. Reduce the amount of dopamine and acetylcholine: This is not the correct approach. Decreasing both dopamine and acetylcholine would exacerbate the symptoms of Parkinson's disease, as the primary issue is the deficiency of dopamine.